SW

Stacie Weninger

Executive Director at F-Prime Biomedical Research Initiative

Waban, Massachusetts

Overview

Work Experience

FB

F-Prime Biomedical Research Initiative

  • Executive Director

    2009 - Current

    President, Alzforum

F

Fidelity

  • Science Program Director

    2005 - 2009

HU

Harvard University

  • Senior Analyst and Project Manager, Task Force on Women in Science

    2005 - 2005

CP

Cell Press

  • Senior Scientist, Neuron

    2001 - 2005

Education

Investments

Engrail Therapeutics

Series B

Total Funding: $220M

Neumora Therapeutics

Series A

Total Funding: $510M

Atalanta Therapeutics

Series A

Total Funding: $110M

Denali Therapeutics

Series A

Total Funding: $350M

Relevant Websites